Chronic lymphocytic leukemia (CLL) is the most common leukemia in the Western world. New research published in the Journal of Leukocyte Biology reveals that certain protein markers may indicate which patients have stable forms of CLL and which have more aggressive types.
New research published in the European Journal of Clinical Investigation identifies cardiovascular test results that might help to identify patients hospitalized with COVID-19 who face an especially high risk of dying.
More than 1.5 million children around the world are estimated to have lost at least one parent, custodial grandparent, or grandparent who lived with them due to death related to COVID-19 during the first 14 months of the pandemic, according to a study published today in The Lancet.
An estimated 1.5 million children worldwide have experienced the death of a parent, custodial grandparent, or other relative who cared for them, as a result of COVID-19, according to a new study published in The Lancet.
We must not assume that we will be able to replicate a vaccine within 12 months during the next pandemic. Even if this was accomplished, other interventions would be required to control and mitigate well before the availability of a vaccine.
Scientists synthesized chemical compounds that can stop the degeneration of neurons in Alzheimer's, Parkinson's, and other severe brain pathologies.
Researchers from TMDU and Osaka University have found that a protein called FCHSD1 is involved in the development of emphysema, which is destruction of the tiny air sacs in the lungs, and is a component of chronic pulmonary respiratory disease that causes illness and death worldwide. Mice deficient in FCHSD1 showed less lung damage, inflammation, and cell death. The team were able to uncover the mechanism by which FCHSD1 acts to promote emphysema, which could lead to the development of new treatments.
What The Study Did: This study investigated the association between time spent cycling and the risk of death from cardiovascular disease or any other cause among people with diabetes.
What The Study Did: Researchers investigated whether death, other hospital outcomes and processes of care differed between patients cared for by female and male physicians at hospitals in Canada.
What The Study Did: National health care systems have different capacities to correctly identify people who died of COVID-19. Researchers in this study analyzed the gap between excess mortality and COVID-19 confirmed mortality in 67 countries to determine the extent to which official data on COVID-19 deaths might be considered reliable.